login
Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Pfizer’s Inlyta Receives FDA Approval for Patients With Advanced Kidney Cancer
The health regulator said that the drug can be used to treat patients who do not respond to any other drugs currently available in treating advanced kidney cancer.
The director of the FDA's office of oncology products, Richard Pazdur announced that Inlyta was the seventh drug approved by the agency to treat advanced kidney cancer and the latest approval will provide patients with multiple treatment options.
While Pfizer will be hoping that the approval will help boost their flagging sales following continued poor performance of its cholesterol drug Lipitor, market analysts said that Inlyta will struggle to gain a foothold in a congested market and predicted peak sales of $600 million.
Source-Medindia
|
|
More News on: Cancer and Homeopathy, Urinary Stones In Children, Vesico-Ureteric Reflux Causing UTI in Children, Hydronephrosis / Antenatal Counseling, Kidney Disease, Cancer Facts, Cancer, Tattoos A Body Art, Kidney, Hematuria
 Comment & Contribute
|
Medwonders Health Network
- Health News Index
 | Quiz on Cancer Looking for information on cancer? Go through medindia's Cancer quiz. 
|
- News Quick Links
 | News Central | | Health Watch | |
| Latest Health News | | Health In Focus | |
| News Category (500+) | | Breaking Health News | |
| Popular News | | Celebrating Life | |
| Health News and Press Release | | Medindia - Exclusive | |
| News Photo Gallery | | India Special | |
| News Video Gallery | | Lifestyle and Wellness | |
| News From Other Resources | |||
 |
Kidney
Complete Medindia Resources
|
| News Categories: |
| » | New Quality Standards in Medicines |
| » | Drug for Irregular Heartbeat Gets Green Signal |
| » | Schizophrenia Drug Differentiates Cancer Stem Cells into Less Threatening Cells |
| » | Docs Who Seldom Meet Drug Reps Continue to Prescribe Drugs With FDA “Black Box” Warnings |
| » | Revision in Quality Standards for Heparin |
| More Drug News | |
|
Drug Related News |
||||||||
| » | New Quality Standards in Medicines | » | Drug for Irregular Heartbeat Gets Green Signal | |||||
| » | Schizophrenia Drug Differentiates Cancer Stem Cells into Less Threatening Cells | » | Docs Who Seldom Meet Drug Reps Continue to Prescribe Drugs With FDA “Black Box” Warnings | |||||
| » | Revision in Quality Standards for Heparin | » | Acne Drug Users At High Risk of Developing Eye Infections | |||||
| » | Patients Who Take Antidepressants When in ICU More Likely to Die | » | New Tablet Coating Product by Ideal Cures, In Geneva | |||||
| Read More >> | ||||||||
